The identified hub genes—MYC, EGFR, CDKN2A, ERBB2, CDK1, E2F1, TOP2A, MDM2, TGFB1, and FOXM1—play significant roles in BC progression and are potential biomarkers for diagnosis, prognosis, and therapy. Here, E2F1 is linked to breast cancer.